Put companies on watchlist
Cardiff Lexington Corporation
ISIN: US14146R6018
WKN: A400D3
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Cardiff Lexington · ISIN: US14146R6018 · ACCESS Newswire (ID: 1059380)
12 August 2025 11:21PM

Cardiff Lexington Postpones Second Quarter 2025 Earnings Press Release and Investor Call


LEXINGTON, KY / ACCESS Newswire / August 12, 2025 / Cardiff Lexington Corporation (OTCQB:CDIX) today announced that the Company will postpone the announcement of its second quarter 2025 results and investor conference call. The Company will host an investor conference call as soon as practicable in conjunction with the filing of its second quarter 2025 results, the timing of which will be announced via press release at a later date.

About Cardiff Lexington Corporation:

Cardiff Lexington Corporation is a unique targeted healthcare holding company focused on locating, acquiring, and building middle market, niche companies, primarily in Orthopedics, Spine Care, and Pain Management. Fundamental to the Cardiff Lexington strategy is the service-based partnership culture which emphasizes core values, teamwork, accountability, and performance.

A substantial majority of the Company's revenue is derived from Nova Ortho and Spine, LLC, which operates a group of regional primary specialty and ancillary care facilities throughout Florida and Georgia that provide traumatic injury victims with a full range of diagnostic and surgical services, primary care evaluations, interventional pain management, and specialty consultation services.

For more information on Cardiff Lexington Corporation, you may access the company's website at https://cardifflexington.com/

FORWARD LOOKING STATEMENT: This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. These risks include the failure to meet schedule or performance requirements of the Company's business, the Company's liquidity position, the Company's ability to obtain new business, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties the forward-looking events referred to in this release might not occur.

Use of Non-GAAP Financial Measures

Cardiff Lexington Corporation prepares its consolidated financial statements in accordance with United States generally accepted accounting principles ("GAAP"). In addition to GAAP disclosures, this document contains financial information and measures considered to be "non-GAAP". These non-GAAP measures can be used in order to gain a more complete and accurate understanding of the Company's financial condition and results. Non-GAAP financial measures should be considered in conjunction with, and not as a substitute to GAAP financial measures.

Cardiff Lexington Investor Relations
investorsrelations@cardifflexington.com
(800) 628-2100 ext. 705

or

IMS Investor Relations
cardifflexington@imsinvestorrelations.com
(203) 972-9200

SOURCE: Cardiff Lexington Corporation



View the original press release on ACCESS Newswire

Visual performance / price development - Cardiff Lexington
Smart analysis and research tools can be found here.
MIC: XOTC
Power-Shortcuts

Cardiff Lexington Corporation
This publication was provided by our content partner ACCESS Newswire
ACCESS Newswire
via  
ACCESS Newswire - Newsfeed ©2025
News Distribution Services
Contact:
1 Glenwood Ave, Suite 1001 Raleigh, NC 27603
+‍866.405.3096